BioNTech SE Cash Flows From Used In Investing Activities
BioNTech SE (BNTX) reported Cash Flows From Used In Investing Activities of -EUR 2.47 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-03-10
| Period end | Cash Flows From Used In Investing Activities 12 month | Cash Flows From Used In Investing Activities 12 month as first filed |
|---|---|---|
| 2025-12-31 | -2.47B EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | -2.08B EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | -6.95B EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | -35.30M EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | -566.10M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | -144.80M EUR 20-F · filed 2023-03-27 | -144.85M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | -77.20M EUR 20-F/A · filed 2022-10-26 | -77.11M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | -66.45M EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | -52.55M EUR 20-F · filed 2020-03-31 |